Algentech awarded a grant by the European Space Agency

Algentech has been recently awarded a grant by the European Space Agency via its Open Space Innovation Platform (OSIP). The project entitled “environment resilient plants for space exploration” will focus on the generation of plants engineered to grow in perchlorate-contaminated soil similar to conditions found on Mars. In paralell, different compounds will be tested for… Continue reading Algentech awarded a grant by the European Space Agency

Algentech is proud to announce the publication of its breakthrough chloroplast technology in Nature Plants

Algentech’s disruptive technology was published on June 21, 2021 in the journal Nature Plants https://doi.org/10.1038/s41477-021-00940-y). The process patented by Algentech makes it possible to produce high levels of proteins and nucleic acids in plant chloroplasts. A technological breakthrough of prime interest for many industrial sectors, in search of sustainable bio-based production platforms. The journal Nature… Continue reading Algentech is proud to announce the publication of its breakthrough chloroplast technology in Nature Plants

Neftys Interviews Algentech CSO Isabelle Malcuit

Link to full interview here: Après 10 ans de développement, Algentech veut exporter sa technologie d’édition du génome végétal aux Etats-Unis (neftys.fr) INNOVATIONS D’ENTREPRISES PORTRAITS D’ENTREPRENEURS Il y a un peu plus d’un an, en janvier 2020, la biotech Algentech se voyait délivrer un brevet déposé en 2010 aux Etats-Unis pour sa dernière trouvaille technologique dans… Continue reading Neftys Interviews Algentech CSO Isabelle Malcuit

Algentech Granted US Patent For A Key Genome Editing Technology

ALGENTECH, announces the issuance of a key patent in the field of genome editing by the U.S. Patent Office (U.S. patent number 10457950)The technology claimed by the patent amplifies the effectiveness of gene editing in eukaryotic cells and can be applied in synergy with nucleases, including zinc finger nucleases, TALENs, Crispr-Cas9… Algentech’s invention optimizes the… Continue reading Algentech Granted US Patent For A Key Genome Editing Technology

Published
Categorised as Patents

Algentech achieves a major breakthrough in crop genomics

Algentech announces it has solved a major technological bottleneck in applied plant genomics, by transforming the cotton mitochondrial genome with DNA sequences naturally capable of inducing cytoplasmic male sterility. This breakthrough in molecular genetics can be applied in the fast generation of high yielding hybrid varieties without the requirement of repetitive and time-consuming back-crosses, simply… Continue reading Algentech achieves a major breakthrough in crop genomics

BIO World Congress on Industrial Biotechnology

Alexander Sorokin, CEO is at the 2018 BIO World Congress on Industrial Biotechnology held in Philadelphia, July 17-19 2018 (https://www.bio.org/events/bio-world-congress ) The BIO World Congress on Industrial Biotechnology provides a unique forum for business executives, government officials, academic researchers and industry leaders to share the latest advances in renewable chemicals, synthetic biology, enzymes, food ingredients, biofuels, algae and more.… Continue reading BIO World Congress on Industrial Biotechnology

Published
Categorised as Congress

Hydrozyme selected by Superbio

Algentech’s Hydrozyme project has been selected for innovation funding from the SuperBIO Horizon 2020 Project! The Hydrozyme system is designed to use the potential of our chloroplast production platform to generate enzymes involved in bio-hydrogen production using biomass. With SuperBIO’s support we will soon launch pilot studies on our plant cell lines to test for… Continue reading Hydrozyme selected by Superbio

Alexander Sorokin, CEO and Isabelle Malcuit, CSO will be taking part in the 2018 BIO International Convention held in Boston,MA, June 4-7 2018 (http://convention.bio.org)

Alexander Sorokin, CEO and Isabelle Malcuit, CSO will be taking part in the 2018 BIO International Convention held in Boston,MA, June 4-7 2018 (http://convention.bio.org) Hosted by the Biotechnology Innovation Organization (BIO), it is the world’s largest biotechnology business partnering event, the BIO International Convention will take place at the Convention and Exhibition Center in Boston. Alexander and Isabelle will… Continue reading Alexander Sorokin, CEO and Isabelle Malcuit, CSO will be taking part in the 2018 BIO International Convention held in Boston,MA, June 4-7 2018 (http://convention.bio.org)

Published
Categorised as Congress